News about Kymos Group

U-Shape and Lean Lab: Improving productivity in the laboratory

The landscape of the life sciences ecosystem is ever-changing, and laboratory operations continually adapt to meet market demands, with efficiency and productivity crucial to the industry's evolution. Among the key drivers of this transformation are the adoption of methodologies like the Lean Lab principles and U-shape layout methodologies. These philosophies and strategies stand as vital (...)

By Carles Celma|2024-08-14T11:15:41+02:00November 21st, 2023|CMC, Kymos Group|Comments Off

Kymos and Prolytic are CIR certified

In addition to Kymos, which has been CIR certified for quite some time, our German subsidiary Prolytic has been approved a CIR certification as well. Now your R&D activities (from Early Phase up to Phase IV projects) performed at Kymos and Prolytic are eligible to CIR. You can recover up to 30% of the amount (...)

By Joan Puig de Dou|2024-08-14T10:50:00+02:00January 31st, 2023|Kymos Group, News|Comments Off

Kymos Christmas Calendar

This year the whole team of Kymos has a Christmas surprise for our clients and partners: An Online Christmas Calendar (Click here) Click on the link and find the Christmas greetings from our individual departments. Open a door every day, see funny and contemplative moments and find a surprise or two. We all had a (...)

By Joan Puig de Dou|2024-08-14T10:51:24+02:00November 30th, 2022|Kymos Group|Comments Off

Solar Panels at Kymos

Climate change, gas and electricity crisis, high inflation. These are challenges all of us are facing every day. Kymos is now taking action: We have invested in sustainability and in our future with new SolarPannels on Kymos buildings. The new photovoltaic installation is composed of 264 solar panels of 490Wp, which means 129.36 kWp of (...)

By Joan Puig de Dou|2024-08-14T11:14:20+02:00September 14th, 2022|Kymos Group|Comments Off

Pharmaprogress – Bright lights are on the horizon

In 2023, Pharmaprogress will move into a more spacious, convenient, and state-of-the-art building in the Ancona area. Luca Gramaccioni, General Site Manager of Pharmaprogress, and his team are excited about having more room soon: "In 2001, Pharmaprogress was established in the current building. After 20 years the team increased from the original 6 to (...)

By Joan Puig de Dou|2024-08-14T11:12:37+02:00May 24th, 2022|Kymos Group|Comments Off

Prolytic and Aeterna Zentaris – 20 years of improving human health together

For almost 20 years, Kymos’ German subsidiary Prolytic has accompanied Aeterna Zentaris in its development of pharmaceutical and diagnostic products. Katrin Dorfmeyer, Head of Chromatography, at Prolytic, and Dr. Michael Teifel, CSO at Aeterna Zentaris, shed light on the interesting project of the growth hormone secretagogue macimorelin (Macrilen, Ghryvelin) which they have been working (...)

By Joan Puig de Dou|2024-08-14T10:53:07+02:00March 22nd, 2022|Kymos Group, News|Comments Off

Kymos and ISGlobal join efforts to STOP parasitic diseases in Africa

“Kymos is a group with the highest ethical standards. This is not a PR statement but our day-to-day philosophy” Dr. Carles Celma, Scientific Director at Kymos stresses. “It was our pleasure to take an active role in the STOP project for the treatment of intestinal parasites in developing countries as soon as ISGlobal approached us.” (...)

By Joan Puig de Dou|2024-08-14T10:49:41+02:00November 30th, 2021|Kymos Group, News|Comments Off

Microbiology: Adding Value to a Full Service

At Kymos, recognized leader in comprehensive laboratory testing, we are privileged to have an entire department dedicated to microbiological testing for sterile and non-sterile API’s and drug products. Karen Reboulaz, Manager of the Microbiology Department, shares with us a deeper insight in her team’s work and the reasons why a significantly increasing number of (...)

By Joan Puig de Dou|2024-08-14T10:53:29+02:00November 3rd, 2021|CMC, Kymos Group|Comments Off

Pharmaprogress’ First-Hand Nitrosamine Experience: Pushing the Analytical Envelope

We are pleased to announce that Dr Luca Gramaccioni, General Site Manager at Kymos Italian Site Pharmaprogress, has been asked to share his analytical experience on nitrosamines in yet another webinar – this time the AFI Symposium 2021 hosted by the Associazione Farmaceutici Industria on September 24th. In anticipation for the event, he and (...)

By Joan Puig de Dou|2024-08-14T11:12:57+02:00September 28th, 2021|Kymos Group|Comments Off

Percutaneous Absorption: Like a Second Skin

An important function of the skin is to protect the body from the environment, and it is normally a very effective barrier against external substances. In some cases, however, penetration of active substances (API) into the skin is desired to provide a therapeutic effect. Hence, manufacturers of pharmaceutical topical products must test how well (...)

By Carles Celma|2024-10-24T14:48:36+02:00July 16th, 2021|Bioanalysis, Kymos Group|Comments Off